IMO you will probably not get 18. They may be gone forever. The market quite liked the 10Q and the PR especially the PR which foresees the trial numbers being made up to desired levels early Q1 2010. Let's face it growing exposure of MSBT plus flu and swine on the rise it's probably a done deal.
As for the science itself, confidence simply continues to grow among investors. The CE Mark, anticipated rapid commercialisation throughout Europe and FDA approval are seen as in the bag IMO. I expect a steady rise to 40 cent by EOY then a pullback as we wait on news. If the news is good, we could be saying hello to $2 real fast.
IMO you should pick up some 19s tomorrow but buying at the ask can't hurt with the outlook I think is ahead.
The above is JMO and none of it should be regarded as a buy, sell or hold signal. Do your own DD. I just happen to love this stock and my shares are held extremely tight.
News 
Market Data 
Discover 
